These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10654622)
1. Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit. Brooks RR; Drexler AP; Maynard AE; Al-Khalidi H; Kostreva DR Proc Soc Exp Biol Med; 2000 Feb; 223(2):183-9. PubMed ID: 10654622 [TBL] [Abstract][Full Text] [Related]
2. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction. Drexler AP; Micklas JM; Brooks RR J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084 [TBL] [Abstract][Full Text] [Related]
3. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079 [TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia. Buchanan LV; Kabell G; Brunden MN; Gibson JK J Cardiovasc Pharmacol; 1993 Oct; 22(4):540-9. PubMed ID: 7505355 [TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs. Brooks RR; Finch SL Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of isoproterenol-induced tachycardia by azimilide in the isolated perfused guinea pig heart. Miller KE; Carpenter JF; Brooks RR Cardiovasc Drugs Ther; 1998 Mar; 12(1):83-91. PubMed ID: 9607136 [TBL] [Abstract][Full Text] [Related]
7. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444 [TBL] [Abstract][Full Text] [Related]
8. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs. Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496 [TBL] [Abstract][Full Text] [Related]
9. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference? Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia. Brooks RR; Carpenter JF; Miller KE; Maynard AE Proc Soc Exp Biol Med; 1996 May; 212(1):84-93. PubMed ID: 8618956 [TBL] [Abstract][Full Text] [Related]
11. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats. Mittelstadt SW; Maynard AE; Benn DR; Lowe ER; Kostreva DR Cardiovasc Drugs Ther; 1997 Sep; 11(4):591-8. PubMed ID: 9358964 [TBL] [Abstract][Full Text] [Related]
12. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs. Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982 [TBL] [Abstract][Full Text] [Related]
13. New advances in class III antiarrhythmic drug therapy. Sager PT Curr Opin Cardiol; 1999 Jan; 14(1):15-23. PubMed ID: 9932203 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium. Ducroq J; Rouet R; Puddu PE; Sallé L; Tabourel C; Ducouret P; Gérard JL Eur J Pharmacol; 2005 Aug; 518(2-3):165-74. PubMed ID: 16083874 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes. Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634 [TBL] [Abstract][Full Text] [Related]
16. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. Carlsson L; Almgren O; Duker G J Cardiovasc Pharmacol; 1990 Aug; 16(2):276-85. PubMed ID: 1697384 [TBL] [Abstract][Full Text] [Related]
17. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias. Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738 [TBL] [Abstract][Full Text] [Related]
18. Azimilide dihydrochloride, a novel antiarrhythmic agent. Karam R; Marcello S; Brooks RR; Corey AE; Moore A Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222 [TBL] [Abstract][Full Text] [Related]
19. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models. Xue Y; Yamada C; Chino D; Hashimoto K Eur J Pharmacol; 1999 Jul; 376(1-2):27-35. PubMed ID: 10440086 [TBL] [Abstract][Full Text] [Related]
20. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall. Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]